124 related articles for article (PubMed ID: 8400323)
1. Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.
Scheithauer W; Kornek G; Haider K; Kwasny W; Schenk T; Pirker R; Depisch D
Breast Cancer Res Treat; 1993; 26(1):49-53. PubMed ID: 8400323
[TBL] [Abstract][Full Text] [Related]
2. Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
Br J Cancer; 1996 Nov; 74(10):1668-73. PubMed ID: 8932353
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma.
Agostara B; Gebbia V; Testa A; Cusimano MP; Gebbia N; Callari AM
Tumori; 1994 Feb; 80(1):33-6. PubMed ID: 8191595
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer.
Degardin M; Bonneterre J; Hecquet B; Pion JM; Adenis A; Horner D; Demaille A
Ann Oncol; 1994 May; 5(5):423-6. PubMed ID: 8075049
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C and vinblastine in anthracycline-resistant metastatic breast cancer: a phase II study.
Kalofonos HP; Onyenadum A; Kosmas C; Koutras A; Petsas T; Efthimiou V; Koukouras D; Tzoracolefterakis E; Andrikopoulos P; Androulakis J
Tumori; 2001; 87(6):394-7. PubMed ID: 11989593
[TBL] [Abstract][Full Text] [Related]
6. [Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast].
Bourgeois H; Turpin F; Bouchada M; Volters A; Cvitkovic F; Goupil A; Janvier M; Tubiana-Hulin M; Soulie P; Berlie J; Girard M; Rouëssé J
Bull Cancer; 1998 Sep; 85(9):794-8. PubMed ID: 9817063
[TBL] [Abstract][Full Text] [Related]
7. First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study.
Llombart-Cussac A; Pivot X; Rhor-Alvarado A; Le Cesne A; Le Chevalier T; Tursz T; Spielmann M
Oncology; 1998; 55(5):384-90. PubMed ID: 9732214
[TBL] [Abstract][Full Text] [Related]
8. Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.
Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G
J Chemother; 2003 Dec; 15(6):607-12. PubMed ID: 14998089
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Lang F; Krauss G; Hejna M; Raderer M; Weinländer G; Depisch D; Scheithauer W
Br J Cancer; 1998 Sep; 78(5):673-8. PubMed ID: 9744509
[TBL] [Abstract][Full Text] [Related]
10. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
Farhat F; Kattan JG; Ghosn M
Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
[TBL] [Abstract][Full Text] [Related]
11. MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
Hsu C; Yeh KH; Hong RL; Yang CH; Lin MT; Chen YC; Cheng AL
J Formos Med Assoc; 1997 Mar; 96(3):185-8. PubMed ID: 9080756
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.
Hejna M; Kornek GV; Raderer M; Marosi L; Schneeweiss B; Greul R; Weinländer G; Valencak J; Huber H; Scheithauer W
Oncology; 1998; 55(6):538-42. PubMed ID: 9778620
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C in combination with vinorelbine in anthracycline- and/or taxane-pretreated patients with metastatic breast cancer.
Schippert C; Warm M; Blohmer JU; du Bois A; Lück HJ
Onkologie; 2012; 35(9):500-4. PubMed ID: 23007147
[TBL] [Abstract][Full Text] [Related]
14. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
Conte PF; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi PG; Gentile A
Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.
Keller AM; Mennel RG; Georgoulias VA; Nabholtz JM; Erazo A; Lluch A; Vogel CL; Kaufmann M; von Minckwitz G; Henderson IC; Mellars L; Alland L; Tendler C
J Clin Oncol; 2004 Oct; 22(19):3893-901. PubMed ID: 15459210
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C and vinorelbine in pretreated breast cancer.
Colleoni M; Manente P; Stocker J; Amor H; Lamon S; Nelli P; Vicario G; Sgarbossa G; Graiff C
Tumori; 1997; 83(5):834-6. PubMed ID: 9428918
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
Kusenda Z; Kerger J; Awada A; Geurs F; Van Vreckem A; Habboubi N; Piccart MJ
Support Care Cancer; 1997 Sep; 5(5):414-6. PubMed ID: 9322355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
